Now more than ever, enhancing primary care practices to include CGM capabilities is a crucial goal requiring the support and involvement of the broader healthcare community.
Through the challenges of the Covid-19 pandemic, caring for whole person health is vital for personal wellness and for business.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Livongo saw its membership and revenue double in the first quarter of 2020, leading into the pandemic. The company also landed a large contract with the Government Employee Health Association, a payer that provides insurance to federal employees.
Earlier this year, the company, which raised $3.5 million in 2016, revealed the findings of a three-month study of its technology conducted at Johns Hopkins University.
Insulin prices have shot up nearly 600 percent, according to a congressional study, leading to potentially deadly rationing by many patients.
The company's shares were down more than 40 percent in midday trading as the FDA placed a clinical hold on ZGN-1061, the second such hold the company has experienced in three years.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In an earnings call last week CVS Health CEO Larry Merlo outlined some of the ways that the company is moving forward on plans to reduce medical costs after its $69 billion purchase of Aetna.
In a deal worth up to $25 million for ViaCyte, the companies will work together to create allogeneic stem cell therapies to treat the disease.
The system has an artificial intelligence algorithm that evaluates the images coming from the camera and determines whether or not there's diabetic retinopathy in them,” explained IDx Founder and President Michael Abràmoff. “So it makes a clinical decision, without someone like me being involved — it's fully autonomous.”
It has raised $2.7 million from six investors, according to a Form D filing with the U.S. Securities and Exchange Commission.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
BlueStar requires a prescription from a licensed healthcare provider and can be reimbursed by health plans.
"It's not like we go in our trench coat and a top hat, saying, 'Uh I need the insulin.' The clerks usually don’t know it’s a big secret. They’ll just go, 'Do we sell over-the-counter insulin?' "
Enlibrium's technology, licensed out of UCLA, will use diabetes drug metformin to shut down energy production in cancer cells - providing a potentially new frontline treatment for the disease.
The companion app helps users view results of these tests over time so they can do a better job of managing their condition.
Also, Alphabet has filed for a patent for a laser ablation device to remove surgical tissue through electromagnetic radiation.